Found 7 matching trials
DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)
PHASE1This study will treat patients with diffuse large B-cell lymphoma (DLBCL). ...
Location
Peking University Third Hospital
DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)
PHASE2This study will treat patients with CLL/SLL whose disease comes back or is ...
A Study of DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (TAI-SHAN1)
PHASE1This study is designed to evaluate the safety, tolerability, pharmacokineti...
DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9)
PHASE2This study will treat patients with DLBCL whose disease comes back or is no...
A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)
PHASE2This is a Phase 2, open-label, randomized, multicenter study to assess the ...
Location
Qilu Hospital of Shandong University
A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)
PHASE3This is a phase 3, open-label, randomized, multi-center study assessing the...
Location
First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)
PHASE2This study will treat patients with newly diagnosed diffuse large B-cell ly...
Location
Chongqing University Cancer Hospital